On April 2, 2014, Liu, Changdou published a patent.Electric Literature of 23256-42-0 The title of the patent was Compound dimetridazole premix for controlling avian enterovirus syndrome. And the patent contained the following:
The invention discloses compound dimetridazole premix for controlling avian enterovirus syndrome, comprising by weight%: dimetridazole 10-30, neomycin sulfate 4-10, decoquinate 2-8, lysozyme 10-30, etamsylate 0.5-5, lactic acid TMP 3-10, and pharmaceutically suitable excipients as balance. The invention adopts new and efficient decoquinate as the anticoccidial drugs, has special effect on intestinal infection dimetridazole and neomycin sulfate, has antibacterial, antiviral, anti-inflammatory pain, intestinal mucosa repair effect of lysozyme, efficient hemostatic drug etamsylate and drug synergistic agent in the compound preparation, and has treatment efficiency on avian enterovirus syndrome. The formula is reasonable, scientific, has simple preparation, wide application, can be used as the preferred drug for prevention and treatment of poultry intestinal toxin syndrome. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Electric Literature of 23256-42-0
The Article related to dimetridazole neomycin sulfate decoquinate avian enterovirus syndrome, Pharmaceuticals: Formulation and Compounding and other aspects.Electric Literature of 23256-42-0
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia